項部浮腫測定、項部浮腫検査、項部肥厚測定、項部肥厚検査、後頚部浮腫測定
WordNet
- the act or process of assigning numbers to phenomena according to a rule; "the measurements were carefully done"; "his mental measurings proved remarkably accurate" (同)measuring, measure, mensuration
PrepTutorEJDIC
- 〈U〉『測定』,測量 / 〈C〉《複数形で》『寸法』 / 〈U〉測定法,測量法
- =translucence
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Nuchal translucency and cardiac abnormalities in euploid singleton pregnancies.
- Shamshirsaz AA, Salmanian B, Ravangard SF, Shamshirsaz AA, Javadian P, Borgida A, Turner G, Feldman D, Spiel M, Benn P, Campbell WA.Author information Department of Obstetrics and Gynecology, University of Connecticut Health Center , Farmington, CT , USA .AbstractAbstract Objective: To investigate different cut-off levels of nuchal translucency (NT) to predict abnormal cardiac findings (ACF) in second trimester ultrasound examination and confirmed postnatal congenital heart defects (CHD) in euploid pregnancies. Methods: A retrospective analysis was performed on singleton pregnancies examined in our ultrasound units from 2006 to 2011. Fetuses with an abnormal karyotype were excluded. Different cut-off levels of NT thickness were analyzed to evaluate its performance to detect the ACF on second trimester ultrasound (2nd US) examination and also the CHD detected in neonatal follow-up evaluation of ACF cases. Results: Of the 12 840 cases, a total number of 8541 euploid pregnancies were included in the study. Thirty-three had ACFs detected by 2nd US (3.86/1000). The mean NT thickness was found to be higher in fetuses with ACFs (p < 0.0001). Of 33 ACFs, 17 (52%, 1.99/1000) had major CHDs in neonatal follow-up. The area under the ROC curves for NT thickness to predict ACFs and CHDs were 0.67 and 0.65, respectively. Conclusions: Higher NT thickness is associated with higher risk of ACF. NT is a weak predictor of ACF and major CHD; however, fetuses with an unexplained increase in NT measurement should be referred for further cardiac investigations.
- The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.J Matern Fetal Neonatal Med.2014 Mar;27(5):495-9. doi: 10.3109/14767058.2013.819336. Epub 2013 Jul 19.
- Abstract Objective: To investigate different cut-off levels of nuchal translucency (NT) to predict abnormal cardiac findings (ACF) in second trimester ultrasound examination and confirmed postnatal congenital heart defects (CHD) in euploid pregnancies. Methods: A retrospective analysis was performed
- PMID 23806115
- Extended First-Trimester Screening Using Multiple Sonographic Markers and Maternal Serum Biochemistry: A Five-Year Prospective Study.
- Hsiao CH, Cheng PJ, Shaw SW, Hsu JJ, Chen RC, Tseng YJ, Chu WC.Author information Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, Taipei, Taiwan, ROC.AbstractObjective: To examine the performance of first-trimester screening test combining several fetal sonographic and maternal biochemical markers for major aneuploidy in a Chinese population. Methods: This was a prospective study performed over 5 years between January 2005 and December 2010 in Taiwan, with 20,586 cases that had a combination of a variety of sonographic markers and maternal serological β-human chorionic gonadotropin and pregnancy-associated plasma protein-A levels assessed at first trimester screening between 11+0 and 13+6 weeks of gestation. The risk of aneuploidy was calculated using algorithm software developed by Fetal Medicine Foundation, London. Fetal karyotyping was performed when the prenatal screening showed a risk of 1/300 or higher. All cases were followed for fetal outcome. Results: The study population was divided into four groups according to the screening strategy performed. The combination of maternal serological biochemistry and nuchal translucency measurement had a 66.7% detection rate of trisomy 21. Addition of nasal bone status increased the detection rate of trisomy 21 to 88.2%. Inclusion of tricuspid regurgitation flow showed an 87.5% detection rate of trisomy 21. Further inclusion of ductus venosus flow increased the detection rate of trisomy 21 to 100%. Incorporating more markers greatly increased the detection rate and decreased the false-positive rate (FPR). Conclusion: Extension of first-trimester screening to include more sonographic markers greatly increased the sensitivity and decreased FPR for detection of chromosomal abnormalities. Such screening strategy is effective in clinical practice for the Chinese ethnic population. © 2014 S. Karger AG, Basel.
- Fetal diagnosis and therapy.Fetal Diagn Ther.2014 Feb 6. [Epub ahead of print]
- Objective: To examine the performance of first-trimester screening test combining several fetal sonographic and maternal biochemical markers for major aneuploidy in a Chinese population. Methods: This was a prospective study performed over 5 years between January 2005 and December 2010 in Taiwan, wi
- PMID 24503519
- Obstetric, Perinatal, and Fetal Outcomes in Pregnancies With False-Positive Integrated Screening Results.
- Baer RJ, Currier RJ, Norton ME, Flessel MC, Goldman S, Towner D, Jelliffe-Pawlowski LL.Author information Genetic Disease Screening Program, California Department of Public Health, Richmond, and the Division of Maternal Fetal Medicine, University of California, San Francisco, and the Department of Epidemiology and Biostatistics, University of California San Francisco School of Medicine, San Francisco, California; and the Division of Maternal Fetal Medicine, University of Hawaii, Honolulu, Hawaii.AbstractOBJECTIVE:: To assess the risk of adverse obstetric, perinatal, and fetal outcomes for pregnant women participating in prenatal sequential integrated screening through the California Prenatal Screening Program who had a false-positive screening result.
- Obstetrics and gynecology.Obstet Gynecol.2014 Feb 4. [Epub ahead of print]
- OBJECTIVE:: To assess the risk of adverse obstetric, perinatal, and fetal outcomes for pregnant women participating in prenatal sequential integrated screening through the California Prenatal Screening Program who had a false-positive screening result.METHODS:: Women who underwent first- and second-
- PMID 24499760
Japanese Journal
- 市塚 清健,長谷川 潤一,松岡 隆,仲村 将光,関沢 明彦
- 超音波医学 41(3), 301-308, 2014
- … 妊娠の診断，比較的大きな胎児形態異常の有無，多胎妊娠の場合の膜性診断，子宮筋腫，卵巣腫瘍など婦人科疾患合併の有無などの検索である．最近では，それらに加え後頸部無エコー領域（nuchal translucency: NT）をはじめとした胎児染色体異常のリスク評価も加わってきた．NT以外の検査項目は，特に倫理的な問題は含んでおらず，基本的には診断した医師は患者に検査結果を伝える必要があるが，N …
- NAID 130004496919
- The dilemma surrounding nuchal translucency-thickness measurement in Japan
- KOZUMA Shiro
- Journal of medical ultrasonics : official journal of the Japan Society of Ultrasonics in Medicine 32(3), 89-90, 2005-09-15
- NAID 10019353218
Related Links
- The nuchal translucency scan is a non-invasive prenatal test in the first trimester. Find out what it can tell you about your baby's risk for Down syndrome a...
- Holders of the FMF certificate in measurement of NT To view the list of sonographers who have obtained the certificate of competence in measurement of nuchal translucency please click here. NT specialists with successful audit To ...
★リンクテーブル★
[★]
- 英
- nuchal translucency measurement
- 関
- 項部浮腫測定、項部肥厚測定、項部肥厚検査、後頚部浮腫測定
[★]
- 英
- nuchal translucency measurement
- 関
- 項部肥厚測定、項部肥厚検査、項部浮腫検査、後頚部浮腫測定
[★]
- 英
- nuchal translucency measurement
- 関
- 項部浮腫測定、項部肥厚測定、項部浮腫検査、後頚部浮腫測定
[★]
- 英
- nuchal translucency measurement
- 関
- 項部浮腫測定、項部肥厚検査、項部浮腫検査、後頚部浮腫測定
[★]
- 英
- nuchal translucency measurement
- 関
- 項部浮腫測定、項部肥厚測定、項部肥厚検査、項部浮腫検査
[★]
- 関
- data quality、determine、estimate、experimental design、fathom、matched group、measure、research design、scoring method、testing
[★]
- 関
- translucent
[★]
項部、項
- 関
- nape、nuchal
[★]
- 関
- nape、nucha